English (United Kingdom)Русский (Russian Federation)

Cromos Pharma - full service contract-research organization for clinical outsourcing to Russia and Ukraine

Cromos™ Pharma is a contract research organization (CRO) that specializes in biopharmaceutical clinical outsourcing to Russia, Ukraine and countries of Eastern Europe – areas with the most compelling environment for biopharmaceutical research. We manage Phase I-IV clinical trials in Russia and Ukraine, as well as bioequivalence and observational studies. The company is trademark-protected (registration no. 1005553) and has been successfully operating since 2005.

Full compliance with ICH GCP regulations, motivated and experienced investigators with impeccable reputations, a large pool of compliant study subjects is the integral to our goal of providing high quality and affordable CRO services.

We offer budget-friendly clinical outsourcing solutions via innovative operational structure and project-specific alliances. We guarantee speed, quality, and best experts in the field. Intricate knowledge of the market, long-term working relationship and personal ties with the best research centers and authorities give us a unique opportunity to accomplish the most difficult tasks in the shortest period of time.

Ready to outsource? Contact a Cromos Pharma representative now.

 
News and messages from CEO,
Dr Vladimir Bogin
12.01.2012

Cromos Pharma has participated in the conference on clinical trials in emerging markets in Tel-Aviv, Israel on 11 January 2012.

[...]

05.01.2012

Meet Cromos Pharma's CEO, Dr. Vladimir Bogin at the 30th JP Morgan Healthcare Conference in San Francisco, CA on 9-12 January 2012.

[...]

14.12.2011

Cromos Pharma published a white paper with review of Russian clinical trials market in 2011.

[...]

28.10.2011

Cromos Pharma's CEO, Dr. Vladimir Bogin has participated in the annual Rusnanotech forum in Moscow, Russia on 25-28 October 2011 .

[...]

27.09.2011

Meet us at 17th Annual International Partnering Conference BIO-Europe 2011 in Duesseldorf, Germany on 31 October - 02 November 2011.

[...]